Catabay, A.; Taniguchi, M.; Jinno, K.; Pesek, J. J.; Williamsen, E. (ngày 1 tháng 3 năm 1998). “Separation of 1,4-Benzodiazepines and Analogues Using Cholesteryl-10-Undecenoate Bonded Phase in Microcolumn Liquid Chromatography”. Journal of Chromatographic Science. 36 (3): 113. doi:10.1093/chromsci/36.3.111.
Langley, MS; Clissold, SP (1988). “Brotizolam. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as a hypnotic”. Drugs. 35 (2): 104–22. doi:10.2165/00003495-198835020-00002. PMID3281819.
Rickels, K. (1986). “The clinical use of hypnotics: indications for use and the need for a variety of hypnotics”. Acta Psychiatrica Scandinavica. 74: 132–41. doi:10.1111/j.1600-0447.1986.tb08990.x. PMID2883820.
Nishiyama, Tomoki; Yamashita, Koichi; Yokoyama, Takeshi; Imoto, Akinobu; Manabe, Masanobu (2007). “Effects of quazepam as a preoperative night hypnotic: comparison with brotizolam”. Journal of Anesthesia. 21 (1): 7–12. doi:10.1007/s00540-006-0445-2. PMID17285406.
Noguchi, Hideaki; Kitazumi, Kazuhiro; Mori, Megumi; Shiba, Toshiharu (2004). “Electroencephalographic Properties of Zaleplon, a Non-Benzodiazepine Sedative/Hypnotic, in Rats”. Journal of Pharmacological Sciences. 94 (3): 246–51. doi:10.1254/jphs.94.246. PMID15037809.
Lee, KK; Chan, TY; Chan, AW; Lau, GS; Critchley, JA (1995). “Use and abuse of benzodiazepines in Hong Kong 1990-1993--the impact of regulatory changes”. Journal of Toxicology. Clinical Toxicology. 33 (6): 597–602. doi:10.3109/15563659509010615. PMID8523479.
Langley, MS; Clissold, SP (1988). “Brotizolam. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy as a hypnotic”. Drugs. 35 (2): 104–22. doi:10.2165/00003495-198835020-00002. PMID3281819.
Rickels, K. (1986). “The clinical use of hypnotics: indications for use and the need for a variety of hypnotics”. Acta Psychiatrica Scandinavica. 74: 132–41. doi:10.1111/j.1600-0447.1986.tb08990.x. PMID2883820.
Nishiyama, Tomoki; Yamashita, Koichi; Yokoyama, Takeshi; Imoto, Akinobu; Manabe, Masanobu (2007). “Effects of quazepam as a preoperative night hypnotic: comparison with brotizolam”. Journal of Anesthesia. 21 (1): 7–12. doi:10.1007/s00540-006-0445-2. PMID17285406.
Yasui, M; Kato, A; Kanemasa, T; Murata, S; Nishitomi, K; Koike, K; Tai, N; Shinohara, S; Tokomura, M (2005). “Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes”. Nihon Shinkei Seishin Yakurigaku Zasshi. 25 (3): 143–51. PMID16045197.
Noguchi, Hideaki; Kitazumi, Kazuhiro; Mori, Megumi; Shiba, Toshiharu (2004). “Electroencephalographic Properties of Zaleplon, a Non-Benzodiazepine Sedative/Hypnotic, in Rats”. Journal of Pharmacological Sciences. 94 (3): 246–51. doi:10.1254/jphs.94.246. PMID15037809.
Griffiths, RR; Johnson, MW (2005). “Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds”. The Journal of Clinical Psychiatry. 66 (Suppl 9): 31–41. PMID16336040.
Lee, KK; Chan, TY; Chan, AW; Lau, GS; Critchley, JA (1995). “Use and abuse of benzodiazepines in Hong Kong 1990-1993--the impact of regulatory changes”. Journal of Toxicology. Clinical Toxicology. 33 (6): 597–602. doi:10.3109/15563659509010615. PMID8523479.